北京慧宝源生物技术股份有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
R&D Milestone: HebaBiz Biotech's application for phase III clinical trial in China for Clevudine (L-FMAU), an anti-hepatitis B virus drug candidate under development has been approved 2021-11-15 22:47
HebaBiz Biotech's anti-cancer drug candidate under development Siroquine (JP001) has been approved for IND clinical trials in the United States 2021-08-20 19:45
1